Joanna L Selfe (J Selfe, Joanna Selfe)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 5

Top Topics

Monoclonal Antibody

Top Venues

The Journal of pathology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Rachel J Evans, Douglas W Perkins, Joanna L Selfe, Anna Kelsey, Gavin P Birch, Janet M Shipley, Koen Schipper, Clare M Isacke
Endo180 (MRC2) antibody-drug conjugate for the treatment of sarcoma. Molecular cancer therapeutics (2022)
Jack F Shern, Joanna L Selfe, Elisa Izquierdo, Rajesh Patidar, Hsien-Chao Chou, Young K Song, Marielle E Yohe, Sivasish Sindiri, Jun S Wei, Xinyu Wen, Erin R Rudzinski, Donald A Barkauskas, Tammy Lo, David C Hall, Corinne M Linardic, Debbie Hughes, Sabri Jamal, Meriel Jenney, Julia C Chisholm, Rebecca Brown, Kristine Jones, Belynda D Hicks, Paola Angelini, Sally L George, Louis Chesler, Michael Hubank, Anna Kelsey, Susanne Andrea Gatz, Stephen X Skapek, Douglas S Hawkins, Janet M Shipley, Javed Khan
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)
Joanna L Selfe, J M Shipley
IGF signalling in germ cells and testicular germ cell tumours: roles and therapeutic approaches. Andrology 7 (4) (2019)
Joanna L Selfe, Neil C Goddard, Alan McIntyre, Kathryn R Taylor, Jane Renshaw, Sergey D Popov, Khin Thway, Brenda Summersgill, Robert A Huddart, Duncan C Gilbert, Janet M Shipley
IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance. The Journal of pathology 244 (2) (2018)
Joanna L Selfe, Janet Shipley
Fusion gene addiction: can tumours be forced to give up the habit? The Journal of pathology 242 (3) (2017)